Palatin Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTN research report →
Companypalatin.com
Palatin Technologies, Inc. , a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
- CEO
- Carl Spana
- IPO
- 1997
- Employees
- 30
- HQ
- Cranbury, NJ, US
Price Chart
Valuation
- Market Cap
- $379.42M
- P/E
- -2.27
- P/S
- 29.45
- P/B
- 1.34
- EV/EBITDA
- -58.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.76%
- Op Margin
- -50.60%
- Net Margin
- -48.50%
- ROE
- -141.40%
- ROIC
- -59.93%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-17,307,349 · 41.80%
- EPS
- $-32.15 · -1491.58%
- Op Income
- $-17,459,939
- FCF YoY
- 32.37%
Performance & Tape
- 52W High
- $31.00
- 52W Low
- $4.50
- 50D MA
- $19.87
- 200D MA
- $15.11
- Beta
- 0.94
- Avg Volume
- 16.01K
Get TickerSpark's AI analysis on PTN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 25 | WILLS STEPHEN T | other | 26 |
| Dec 30, 25 | WILLS STEPHEN T | other | 91 |
| Dec 30, 25 | WILLS STEPHEN T | other | 95 |
| Dec 30, 25 | SPANA CARL | other | 40 |
| Dec 30, 25 | SPANA CARL | other | 138 |
| Dec 30, 25 | SPANA CARL | other | 143 |
| Dec 24, 25 | WILLS STEPHEN T | sell | 565 |
| Dec 9, 25 | WILLS STEPHEN T | other | 495 |
| Dec 9, 25 | WILLS STEPHEN T | other | 518 |
| Dec 9, 25 | WILLS STEPHEN T | other | 142 |
Our PTN Coverage
We haven't published any research on PTN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PTN Report →